Market revenue in 2023 | USD 11.2 million |
Market revenue in 2030 | USD 18.8 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 47.32% in 2023. Horizon Databook has segmented the UK cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
The UK had 17.7% of the people over the age of 65 in 2014, and this percentage is expected to increase in the coming years. Rising elderly population is driving the demand for better healthcare facilities to increase life expectancy. Growing prevalence of lifestyle-related diseases is likely to drive the growth of the market. The UK has a large and advanced healthcare system, which rapidly adopts new and innovative technologies. The UK was the sixth largest medical devices market in the world in 2015.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account